← Back to Search

Behavioural Intervention

Remote High-Intensity Interval Training for COVID-19 Recovery (REMM-HIIT-CoV Trial)

N/A

Recruiting

Led By Paul Wischmeyer, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Discharged or expected to be discharged directly home from the hospital (not to a skilled nursing facility, inpatient rehabilitation center, or long-term acute care hospital)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

REMM-HIIT-CoV Trial Summary

This trial tests ways to help people who were critically ill with COVID-19 regain physical strength.

Who is the study for?

This trial is for adults over 18 who were hospitalized with COVID-19 and can walk on their own or with a cane. They should be going home directly from the hospital, not to another care facility, and must be able to exercise and use an iPhone for mobile health coaching.Check my eligibility

What is being tested?

The study tests a remote, mobile health-supported rehab program with high-intensity interval training (REMM-HIIT) in patients recovering from severe COVID-19. It's a randomized controlled trial involving 120 participants who complete at least one exercise session.See study design

What are the potential side effects?

While specific side effects are not listed, high-intensity interval training may cause muscle soreness, fatigue, or exacerbate underlying conditions if present. Participants will likely be monitored closely for any adverse reactions.

REMM-HIIT-CoV Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I will be going home directly after my hospital discharge.

Select...

I can walk by myself or with help like a cane before leaving the hospital.

Select...

I was hospitalized due to COVID-19.

REMM-HIIT-CoV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 6 minute walk distance

Secondary outcome measures

Change in 30-sec sit to stand score

Change in Cardiorespiratory fitness

Change in Duke Activity Status Index (DASI) Score

+13 more

Other outcome measures

Change in biomarkers of aging

Change in biomarkers of inflammation

DNA, Mitochondrial

REMM-HIIT-CoV Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: REmotely Monitored, Mobile health supported Multidomain Rehabilitation Program with HIITExperimental Treatment1 Intervention

Patients will receive our REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training Program (REMM-HIIT) with iWatch/iPhone.

Group II: Exercise education without personalized sessions or feedbackActive Control1 Intervention

Patients will receive an exercise handout and iWatch/iPhone. Patients return home to exercise without personalized instruction and coaching.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Florida Atlantic UniversityOTHER

30 Previous Clinical Trials

9,729 Total Patients Enrolled

Duke UniversityLead Sponsor

2,373 Previous Clinical Trials

3,426,537 Total Patients Enrolled

18 Trials studying Critical Illness

10,684 Patients Enrolled for Critical Illness

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,972 Previous Clinical Trials

2,677,342 Total Patients Enrolled

6 Trials studying Critical Illness

2,404 Patients Enrolled for Critical Illness

Media Library

REmotely Monitored, Mhealth supported High Intensity Interval Training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05218083 — N/A

Critical Illness Research Study Groups: REmotely Monitored, Mobile health supported Multidomain Rehabilitation Program with HIIT, Exercise education without personalized sessions or feedback

Critical Illness Clinical Trial 2023: REmotely Monitored, Mhealth supported High Intensity Interval Training Highlights & Side Effects. Trial Name: NCT05218083 — N/A

REmotely Monitored, Mhealth supported High Intensity Interval Training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05218083 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are conducting this experiment?

"The locations accepting participants in this study include Duke University Health System in Durham, The Ohio State University Wexner Medical Center in Columbus, Vanderbilt University Medical Center and 4 other sites."

Answered by AI

Does this research endeavor presently admit participants?

"As reported on clinicaltrials.gov, this research initiative is looking for subjects to participate. It was initially advertised on February 21st 2023 and has been recently updated April 28th 2023."

Answered by AI

How many participants have been recruited to partake in this clinical experiment?

"Affirmative. Per the information on clinicaltrials.gov, this physician-led trial is actively recruiting participants since February 21st 2023 and was last updated on April 28th 2023. The study requires 120 individuals to be enrolled from 4 different medical facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

2023. "REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05218083.

All > Covid 19 > Coronavirus